Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

108.1K
Overview
108.1K
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

6.9K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
6.9K
Infection01:20

Infection

9.5K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
9.5K
Intracellular Movement of Viruses and Bacteria01:10

Intracellular Movement of Viruses and Bacteria

3.1K
Intracellular bacteria and viruses often comprise a group of highly infectious pathogens that can cause several diseases. Bacterial pathogens include those belonging to the genus Rickettsia responsible for conditions such as rocky mountain spotted fever and the Mediterranean spotted fever; Chlamydia, a genus responsible for a sexually transmitted disease; Coxiella burnetii, an agent responsible for Q fever. Viral pathogens include vaccinia—a poxvirus, and herpes simplex virus—a...
3.1K
What are Viruses?00:50

What are Viruses?

122.2K
Overview
122.2K
Viral Structure00:56

Viral Structure

69.0K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
69.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure and receptor recognition of type-II feline infectious peritonitis virus spike glycoprotein.

The EMBO journal·2026
Same author

Genomic and structural evidence of SARS-CoV-2 and MERS-CoV in migratory birds.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Hemagglutinin double-mutation enhances binding of human-infecting avian influenza virus clade 2.3.4.4b H5Ny to human and SLe<sup>X</sup> receptors.

EMBO reports·2026
Same author

Localizing the Glycan Binding Sites of SARS-CoV-2 Receptor-Binding Domain.

Analytical chemistry·2026
Same author

From weak but broad to potent and universal: A trispecific antibody against conserved SARS-CoV-2 spike epitopes.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Multivalent nanoparticles activate T-dependent antibody response via antigen presentation by both B cells and dendritic cells.

Cell reports·2026

Related Experiment Video

Updated: Oct 31, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.3K

Cell entry by SARS-CoV-2.

Ruchao Peng1, Lian-Ao Wu2, Qingling Wang3

  • 1CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS), Beijing 100101, China.

Trends in Biochemical Sciences
|June 30, 2021
PubMed
Summary
This summary is machine-generated.

Severe acute respiratory syndrome virus 2 (SARS-CoV-2) uses its spike protein to enter host cells, primarily binding to angiotensin-converting enzyme 2 (ACE2). Understanding these molecular interactions is key for developing effective vaccines and therapeutics.

Keywords:
COVID-19SARS-CoV-2coreceptormembrane fusionreceptor recognitionspike proteinvirus entry

More Related Videos

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

932
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

791

Related Experiment Videos

Last Updated: Oct 31, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.3K
Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

932
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

791

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is the causative agent of COVID-19.
  • Viral entry into host cells is a critical step in infection and pathogenesis.
  • The spike (S) protein of SARS-CoV-2 mediates host cell recognition and membrane fusion.

Purpose of the Study:

  • To review recent advances in understanding the molecular mechanisms of SARS-CoV-2 entry.
  • To highlight the role of the spike protein, ACE2 receptor, and other cofactors in viral invasion.
  • To discuss how this knowledge can inform the development of vaccines and therapeutics.

Main Methods:

  • Literature review of recent research on SARS-CoV-2 entry mechanisms.
  • Analysis of molecular interactions between viral proteins and host cell factors.
  • Discussion of protease involvement in S protein activation and membrane fusion.

Main Results:

  • Angiotensin-converting enzyme 2 (ACE2) is identified as the major receptor for SARS-CoV-2.
  • Auxiliary receptors and cofactors expand the tropism of SARS-CoV-2.
  • Proteolytic cleavage of the S protein is essential for triggering fusogenic activity.

Conclusions:

  • Understanding the molecular details of SARS-CoV-2 entry is crucial for therapeutic strategies.
  • Targeting viral entry pathways offers potential for vaccine and drug development.
  • Further research into host-pathogen interactions can lead to novel interventions against SARS-CoV-2.